Pharma Sessions cover art

Pharma Sessions

Pharma Sessions

Written by: Jonathan Kaskey
Listen for free

LIMITED TIME OFFER | Get 2 Months for ₹5/month

About this listen

 Navigating pharmaceutical launch excellence through strategy, technology and career stories. (And sharing fun moments too!)© 2025 Pharma Sessions Economics Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • Building a Cancer Medtech Company the Hard Way: Shaun Bagai on Evidence, Strategy, and Growth

    Building a Cancer Medtech Company the Hard Way: Shaun Bagai on Evidence, Strategy, and Growth
    Mar 12 2026
    Drug launches in oncology don’t succeed simply because the technology works; they succeed when the evidence is strong enough to change physician behavior. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Shaun Bagai, CEO of RenovoRx, to discuss the long and uncertain journey of building a medtech company grounded in clinical proof. From turning down medical school to leading a Nasdaq-listed oncology company, Shaun shares how physician feedback reshaped the company’s strategy, why investing in rigorous clinical trials can be a defining leadership decision, and why face-to-face relationships remain essential for market adoption in healthcare. Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice. The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
    Show More Show Less
    31 mins
  • How to Actually Get the Stuff You Want Approved in Pharma

    How to Actually Get the Stuff You Want Approved in Pharma
    Mar 5 2026
    In this solo episode of Pharma Sessions, host Jonathan Kaskey breaks down what actually determines whether a new technology implementation in pharma succeeds or quietly dies in a steering committee meeting. After helping pharma companies implement nearly $200 million in new software platforms over the course of his career, Jonathan shares the patterns he’s seen again and again.
    Show More Show Less
    16 mins
  • How SkinPass Went From Bedside Insight to Retail Scale with Dr. Christopher Otiko

    How SkinPass Went From Bedside Insight to Retail Scale with Dr. Christopher Otiko
    Feb 26 2026
    Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Ana Bozas, Director of Clinical Evidence Strategy and Scientific Communications at Vera Therapeutics, to dive into what launch readiness really means from the medical side. Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice. The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
    Show More Show Less
    26 mins
No reviews yet